OTC Markets OTCPK - Delayed Quote USD

BioAdaptives, Inc. (BDPT)

Compare
0.0003 0.0000 (0.00%)
At close: November 6 at 3:33 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
35.5190
28.5650
17.1760
19.7760
16.3270
Cost of Revenue
24.1400
17.7460
10.0500
9.6710
10.2320
Gross Profit
11.3790
10.8190
7.1260
10.1050
6.0950
Operating Expense
286.8660
239.7400
429.0260
646.1860
260.4210
Operating Income
-275.4870
-228.9210
-421.9000
-636.0810
-254.3260
Net Non Operating Interest Income Expense
-132.1590
-162.8910
-289.1210
-272.3940
-230.3280
Other Income Expense
-363.4700
-320.6540
-184.5490
-141.4730
-362.5900
Pretax Income
-771.0860
-712.4660
-895.5700
-1,049.9480
-847.2440
Net Income Common Stockholders
-771.0860
-712.4660
-895.5700
-1,049.9480
-847.2440
Diluted NI Available to Com Stockholders
-771.0860
-712.4660
-895.5700
-1,049.9480
-847.2440
Basic EPS
-0.00
-0.00
-0.01
-0.03
-0.04
Diluted EPS
-0.00
-0.00
-0.01
-0.03
-0.04
Basic Average Shares
933,940.2980
559,069.0320
106,011.4490
33,742.9200
20,387.7980
Diluted Average Shares
933,940.2980
559,069.0320
106,011.4490
33,742.9200
20,387.7980
Total Operating Income as Reported
-296.8070
-228.9210
-421.9000
--
--
Total Expenses
311.0060
257.4860
439.0760
655.8570
270.6530
Net Income from Continuing & Discontinued Operation
-771.0860
-712.4660
-895.5700
-1,049.9480
-847.2440
Normalized Income
-402.6660
-391.8120
-711.0210
-908.4750
-484.6540
Interest Expense
132.1590
162.8910
289.1210
272.3940
230.3280
Net Interest Income
-132.1590
-162.8910
-289.1210
-272.3940
-230.3280
EBIT
-638.9270
-549.5750
-606.4490
-777.5540
-616.9160
EBITDA
-592.1580
-521.4010
-544.3010
-643.7630
-616.9160
Reconciled Cost of Revenue
42.1400
17.7460
10.0500
9.6710
10.2320
Reconciled Depreciation
28.7690
28.1740
62.1480
133.7910
--
Net Income from Continuing Operation Net Minority Interest
-771.0860
-712.4660
-895.5700
-1,049.9480
-847.2440
Total Unusual Items Excluding Goodwill
-368.4200
-320.6540
-184.5490
-141.4730
-362.5900
Total Unusual Items
-368.4200
-320.6540
-184.5490
-141.4730
-362.5900
Normalized EBITDA
-223.7380
-200.7470
-359.7520
-502.2900
-254.3260
12/31/2020 - 7/9/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers